What is Bendamustine?

Category: Prescription Drugs

Most popular types: Treanda Bendeka


See also: Lenalidomide-bendamustine-dexamethasone

Bendamustine belongs to the group of anti-cancer medicines called alkylating agents. It is used to treat chronic lymphocytic leukemia, a type of cancer of the white blood cells. It can also be used for other types of blood cancers such as Hodgkin and non-Hodgkin lymphoma as well as multiple myeloma.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Chronic lymphocytic leukemia 7 5
Non-Hodgkin's lymphoma 5 3
Follicular lymphoma 3 0
Hodgkin's lymphoma 1 0
MALT lymphoma 1 0
Mantle cell lymphoma 1 1

Show all 7 reasons taken

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 3
Moderate 3
Mild 4
None 0

Commonly reported side effects and conditions associated with Bendamustine

Side effect Patients Percentage
Nausea 4
Tiredness 2
Constant tiredness 1
Flushing 1
Infection of uncertain origin 1
Swollen veins in arms 1

Show all 7 reported side effects

Why patients stopped taking Bendamustine

Multiple reasons could be selected

Reason Patients Percentage
Course of treatment ended 3
Did not seem to work 1
Doctor's advice 1
Other 1
See all 5 patients who've stopped taking Bendamustine


Stopped taking Bendamustine

Duration Patients Percentage
Less than 1 month 1
1 - 6 months 2
6 months - 1 year 1
2 - 5 years 1
Adherence Evaluations Percentage
Always 7
Usually 1
Sometimes 0
Never taken as prescribed 2
Burden Evaluations Percentage
Very hard to take 1
Somewhat hard to take 2
A little hard to take 4
Not at all hard to take 3
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 1
$50-99 0
$25-49 0
< $25 1
Not specified 8

What people switch to and from

Patients started taking Bendamustine after stopping:

Treatment Patients Percentage
Fludarabine (Fludara) 1
Ibrutinib (Imbruvica) 1
Lenalidomide (Revlimid) 1
Rituximab (Rituxan) 1

Patients stopped taking Bendamustine and switched to:

Treatment Patients Percentage
Ibrutinib (Imbruvica) 3
Obinutuzumab (Gazyva) 1
Last updated:

1 patient evaluation for Bendamustine

May 23, 2018 (Started Feb 28, 2017)

  • Effectiveness
    Major (for non-Hodgkin's lymphoma)
  • Side effects
    Moderate (nausea, swollen veins in arms, overwhelming fatigue)
  • Adherence
  • Burden
    Somewhat hard to take
Dosage: 150 mg Monthly
Advice & Tips: I am back on Bendeka and Gozyva - same dosages as before. I have asked the nurses administering my infusions of Bendeka to slow the drip to 30 minutes (versus the 10 minutes as prescribed) - this seems to do less damage to my veins and surrounding nerves. We shall see as the next 5 months of treatments go by.

Mar 8, 2017 (Started Feb 28, 2017)

  • Effectiveness
    Can't tell (for non-Hodgkin's lymphoma)
  • Side effects
    Severe (nausea, swollen veins in arms, overwhelming fatigue)
  • Adherence
  • Burden
    Very hard to take
Dosage: 150 mg Monthly
Advice & Tips: I had 2 infusions of Bendeka over two days at 75 MG per day along with 1000 MG Gazeva (this is a new RX because Rituxan no longer has any effect on my lymphoma) . My arm began to burn at the infusion site after a few minutes, the veins red turned red and the redness extended up the vein for several days, as did moderate pain. After one week, the veins are still visibly swollen and discolored. My arm feels like I was struck hard with something like a baseball bat. Aside from my arm, I have been flat on my butt for the past 5 days - I think I am finally getting some energy back. This stuff definitely got my attention.

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Bendamustine